Inventor · disambiguated record
Daniel Paul Teufel
Also filed as: TEUFEL DANIEL · TEUFEL DANIEL PAUL
29 granted patents·20 pending applications·508 citations·filing 2010–2025
97Inventor score
Files withBICYCLERD LTD25BICYCLETX LTD14BICYCLE THERAPEUTICS LTD5BOEHRINGER INGELHEIM INT2WINTER GREGORY PAUL2
Top patents by PatentIndex Score
49 records- 0197US11241473B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Feb 8, 2022·16 cites·27 claims
- 0296US11746126B2Bicyclic peptide ligands with detectable moieties and uses thereofBICYCLERD LTD·Filed 2020·Granted Sep 5, 2023·15 cites·22 claims
- 0396US11672868B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2021·Granted Jun 13, 2023·16 cites·19 claims
- 0496US11103591B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2019·Granted Aug 31, 2021·20 cites·24 claims
- 0596US10792368B1Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2020·Granted Oct 6, 2020·23 cites·14 claims
- 0696US10624968B2Compounds for treating cancerBICYCLE THERAPEUTICS LTD·Filed 2018·Granted Apr 21, 2020·31 cites·30 claims
- 0796US10441663B2Methods for treating cancerBICYCLE THERAPEUTICS LTD·Filed 2017·Granted Oct 15, 2019·34 cites·22 claims
- 0896US9670482B2Multispecific peptidesBICYCLE THERAPEUTICS LTD·Filed 2013·Granted Jun 6, 2017·29 cites·1 claims
- 0995US11433137B2Compounds for treating cancerBICYCLERD LTD·Filed 2019·Granted Sep 6, 2022·15 cites·28 claims
- 1095US10994019B2Bicyclic peptide-toxin conjugates specific for MT1-MMPBICYCLERD LTD·Filed 2017·Granted May 4, 2021·20 cites·17 claims
- 1195US10899798B2Bicyclic peptide ligands with detectable moieties and uses thereofBICYCLERD LTD·Filed 2018·Granted Jan 26, 2021·20 cites·17 claims
- 1295US10894808B2Polypeptide ligands specific for plasma kallikreinBICYCLERD LTD·Filed 2019·Granted Jan 19, 2021·17 cites·42 claims
- 1395US10857196B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2018·Granted Dec 8, 2020·20 cites·20 claims
- 1495US8685890B2Multispecific peptidesWINTER GREGORY PAUL·Filed 2010·Granted Apr 1, 2014·34 cites·11 claims
- 1594US11814447B2Peptide ligands for binding to EphA2BICYCLERD LTD·Filed 2019·Granted Nov 14, 2023·14 cites·19 claims
- 1694US11730819B2Peptide derivatives having novel linkage structuresBICYCLETX LTD·Filed 2017·Granted Aug 22, 2023·15 cites·23 claims
- 1794US11623012B2Bicyclic peptide ligands specific for EphA2BICYCLERD LTD·Filed 2018·Granted Apr 11, 2023·15 cites·9 claims
- 1894US10800813B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2012·Granted Oct 13, 2020·24 cites·48 claims
- 1994US10532106B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2015·Granted Jan 14, 2020·32 cites·12 claims
- 2094US9518081B2Peptide librariesWINTER GREGORY PAUL·Filed 2010·Granted Dec 13, 2016·26 cites·11 claims
- 2193US12318454B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2023·Granted Jun 3, 2025·1 cites·13 claims
- 2293US10294274B2Polypeptide ligands specific for plasma kallikreinBICYCLERD LTD·Filed 2014·Granted May 21, 2019·27 cites·2 claims
- 2393US10118947B2Modulation of structured polypeptide specificityBICYCLE THERAPEUTICS LTD·Filed 2014·Granted Nov 6, 2018·27 cites·6 claims
- 2492US10870679B2Modulation of structured polypeptide specificityBICYLERD LTD·Filed 2018·Granted Dec 22, 2020·17 cites·21 claims
- 2582US2025255975A1Bicyclic peptide ligands specific for mt1-mmpBICYCLERD LTD·Filed 2025·Application pending·0 cites
- 2673US2023340020A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 2772US2025230191A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2025·Application pending·0 cites
- 2868US11912794B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2020·Granted Feb 27, 2024·0 cites·19 claims
- 2968US11753444B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2020·Granted Sep 12, 2023·0 cites·21 claims
- 3063US2024279278A1Nmu receptor 2 agonistsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3163US2024247080A1Glp1/gip/npy2 receptor triple agonistsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3262US2024408219A1Bicyclic peptide ligand drug conjugatesBICYCLERD LTD·Filed 2022·Application pending·0 cites
- 3362US2019389907A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2017·Application pending·0 cites
- 3459US12377155B2Bicyclic peptide ligands specific for PSMABICYCLERD LTD·Filed 2019·Granted Aug 5, 2025·0 cites·14 claims
- 3554US12350343B2Bicyclic peptide ligands specific for MT1-MMPBICYCLETX LTD·Filed 2019·Granted Jul 8, 2025·0 cites·17 claims
- 3652US12491253B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2019·Granted Dec 9, 2025·0 cites·15 claims
- 3752US2022194983A1Peptide ligands for binding to psmaBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 3851US2021122785A1Peptide ligands for binding to il-17BICYCLETX LTD·Filed 2019·Application pending·0 cites
- 3951US2021147485A1Peptide ligands for binding to integrinBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 4051US2021122804A1Peptide ligands for binding to cd38BICYCLETX LTD·Filed 2019·Application pending·0 cites
- 4150US2017067045A1Peptide librariesBICYCLE THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 4250US2022024982A1Bicyclic peptide ligands specific for mt1-mmpBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 4350US2022135614A1Synthesis of bicycle toxin conjugates, and intermediates thereofBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 4449US2022064221A1Bicyclic peptide ligands specific for integrin alpha-v-beta-3BICYCLETX LTD·Filed 2020·Application pending·0 cites
- 4549US2022133733A1Bicyclic peptide ligands specific for cd38BICYCLERD LTD·Filed 2020·Application pending·0 cites
- 4649US2022133732A1Bicyclic peptide ligands specific for caixBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 4749US2022088118A1Bicyclic peptide ligands specific for caixBICYCLETX LTD·Filed 2020·Application pending·0 cites
- 4849US2022119488A1Bicyclic peptide ligands specific for integrin alpha-v-beta-3BICYCLERD LTD·Filed 2020·Application pending·0 cites
- 4946US2022024983A1Bicyclic peptide ligands specific for il-17BICYCLERD LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Paul Teufel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →